Other studies have found a link between taking the pill and cervical cancer, but this is the first to show how long this risk persists, according to the study in The Lancet, a UK medical journal.
Dr Jane Green, a cancer epidemiologist from Britain's University of Oxford, studied data from 24 studies involving more than 16 000 women with cervical cancer and more than 35 000 without.
How the study was done
For women in developed countries who took the pill from age 20 to 30, the number of cases of cervical cancer by age 50 rises to 4.5 per 1 000 women, from 3.8 cases per 1 000 in women who did not take the pill.
The incidence rises to 8.3 cases per 1 000 for pill users in less developed countries, compared with 7.3 cases per 1 000 for women who did not take the pill.
But this extra risk is outweighed by a reduction in the risk of ovarian and endometrial cancers, the researchers said.
Cancer researcher Ciaran Woodman, of the University of Birmingham, said the study reinforces the need for routine screening for cervical cancer.
Women should all be screened regularly
"The take-home message should be that all women must come for screening when invited," she said.
Cervical cancer is the second most common type in women and the leading cause of cancer death in some countries.
Virtually all cases of cervical cancer are caused by the sexually transmitted human papilloma virus (HPV). - ReutersHealth)
Read more:
Pill does not up cancer risk